{"id":3711,"date":"2022-09-03T22:10:00","date_gmt":"2022-09-03T22:10:00","guid":{"rendered":"https:\/\/www.pcube.tech\/blog\/?p=3711"},"modified":"2022-09-14T15:03:55","modified_gmt":"2022-09-14T15:03:55","slug":"opdivo-vs","status":"publish","type":"post","link":"https:\/\/www.pcube.tech\/blog\/opdivo-vs\/","title":{"rendered":"Opdivo vs."},"content":{"rendered":"<h1> Opdivo vs. <\/h1>\n<p> Keytruda <\/p>\n<h2> \u00davod <\/h2>\n<p> Opdivo (nivolumab) a Keytruda (Pembrolizumab) jsou l\u00e9ky na p\u0159edpis zna\u010dky. Jsou schv\u00e1leny spr\u00e1vou potravin a l\u00e9\u010div (FDA) k l\u00e9\u010db\u011b ur\u010dit\u00fdch typ\u016f n\u00e1sleduj\u00edc\u00edch rakovin: <\/p>\n<ul>\n<li> Rakovina mo\u010dov\u00e9ho m\u011bch\u00fd\u0159e <\/li>\n<li> Klasick\u00fd Hodgkin\u016fv lymfom <\/li>\n<li><\/li>\n<li> Rakovina kolorekt\u00e1lu <\/li>\n<li> Rakovina j\u00edcnu <\/li>\n<li> Rakovina ledvin <\/li>\n<li> Rakovina jater <\/li>\n<li> Rakovina k\u016f\u017ee melanomu <\/li>\n<li> Ne-mal\u00fd Rakovina plic bun\u011b\u010dn\u00fdch plic <\/li>\n<li> Rakovina plic s mal\u00fdmi bu\u0148kami <\/li>\n<li> Slo\u017ekov\u00e1 rakovina hlavy a krku <\/li>\n<\/ul>\n<p> Opdivo a Keytruda maj\u00ed tak\u00e9 dal\u0161\u00ed pou\u017eit\u00ed.<!--more--> Krom\u011b toho jsou ob\u011b l\u00e9ky biologick\u00e9 l\u00e9ky. Neexistuj\u00ed biosimilar verze obou l\u00e9k\u016f. L\u00e9ky zna\u010dky jsou \u010dasto dra\u017e\u0161\u00ed ne\u017e biosimilars. O nich budou diskutov\u00e1ny v tomto \u010dl\u00e1nku. <\/p>\n<p> Pozn\u00e1mka: Komplexn\u011bj\u0161\u00ed informace o t\u011bchto dvou drog\u00e1ch naleznete na na\u0161ich \u010dl\u00e1nc\u00edch Opdivo a Keytruda.<\/p>\n<p> Aktivn\u00ed l\u00e9k v Opdivo je nivolumab, zat\u00edmco Keytruda m\u00e1 pembrolizumab jako aktivn\u00ed l\u00e9k. T\u0159\u00edda l\u00e9k\u016f je skupina l\u00e9k\u016f, kter\u00e9 pracuj\u00ed podobn\u00fdm zp\u016fsobem. K l\u00e9\u010db\u011b n\u00e1sleduj\u00edc\u00edch. <\/p>\n<ul>\n<li> Opdivo i Keytruda jsou schv\u00e1leny FDA k l\u00e9\u010db\u011b ur\u010dit\u00fdch typ\u016f: <\/li>\n<\/ul>\n<ul>\n<li> Rakovina mo\u010dov\u00e9ho m\u011bch\u00fd\u0159e <\/li>\n<\/ul>\n<ul>\n<li> Klasick\u00fd Hodgkin\u016fv lymfom <\/li>\n<\/ul>\n<ul>\n<li> Kolorekt\u00e1ln\u00ed rakovina <\/li>\n<\/ul>\n<ul>\n<li> Rakovina j\u00edcnu <\/li>\n<\/ul>\n<ul>\n<li> Rakovina ledvin <\/li>\n<\/ul>\n<ul>\n<li> Rakovina jater <\/li>\n<\/ul>\n<ul>\n<li> Rakovina k\u016f\u017ee melanomu <\/li>\n<\/ul>\n<ul>\n<li> Rakovina plic, kter\u00e1 nekone\u010dn\u00e1 bu\u0148ka <\/li>\n<\/ul>\n<ul>\n<li> Rakovina plic s mal\u00fdmi bu\u0148kami <\/li>\n<\/ul>\n<ul>\n<li> Slop\u00e1\u017en\u00ed hlava a krk bun\u011bk Rakovina <\/li>\n<\/ul>\n<li> Opdivo je tak\u00e9 schv\u00e1lena FDA k l\u00e9\u010db\u011b ur\u010dit\u00e9ho typu: <\/li>\n<li> Keytruda je tak\u00e9 schv\u00e1lena FDA k l\u00e9\u010db\u011b ur\u010dit\u00fdch typ\u016f:\n<ul> <\/ul>\n<\/li>\n<li> Rakovina d\u011blo\u017en\u00edho \u010d\u00edpku <\/li>\n<ul>\n<li> Rakovina Merkelov\u00e9 bun\u011bk <\/li>\n<\/ul>\n<ul>\n<li> Prim\u00e1rn\u00ed mediastin\u00e1ln\u00ed velk\u00fd lymfom B bun\u011bk <\/li>\n<\/ul>\n<ul>\n<li> Rakovina \u017ealudku <\/li>\n<\/ul>\n<ul>\n<li> N\u011bkter\u00e9 metastaty c nebo neresekovateln\u00e9 pevn\u00e9 n\u00e1dory <\/li>\n<\/ul>\n<ul>\n<li> Trojit\u00fd negativn\u00ed rakovina prsu <\/li>\n<\/ul>\n<ul>\n<li> Endometri\u00e1ln\u00ed rakovina <\/li>\n<\/ul>\n<p> Opdivo i Keytruda jsou schv\u00e1leny FDA k l\u00e9\u010db\u011b rakoviny kolorekt\u00e1ln\u00edho kolorekt\u00e1lu u d\u011bt\u00ed. Keytruda je tak\u00e9 schv\u00e1lena FDA k l\u00e9\u010db\u011b jin\u00fdch druh\u016f rakoviny u d\u011bt\u00ed. d\u00e1vky, formy a pod\u00e1v\u00e1n\u00ed <\/p>\n<p> Opdivo i Keytruda p\u0159ich\u00e1zej\u00ed jako kapaln\u00e9 roztoky. Ob\u011b l\u00e9ky jsou pod\u00e1v\u00e1ny jako intraven\u00f3zn\u00ed (iv) infuze, co\u017e je injekce do va\u0161\u00ed \u017e\u00edly, kter\u00e1 byla d\u00e1na po ur\u010ditou dobu. Tyto injekce obdr\u017e\u00edte ve zdravotnick\u00e9m za\u0159\u00edzen\u00ed, jako je infuzn\u00ed centrum nebo nemocnice. Infuze Keytruda se pod\u00e1vaj\u00ed ka\u017ed\u00e9 3 nebo 6 t\u00fddn\u016f. V\u00e1\u0161 rozvrh infuze bude z\u00e1viset na stavu, kter\u00fd pou\u017e\u00edv\u00e1te l\u00e9k k l\u00e9\u010db\u011b, a na konkr\u00e9tn\u00edm pl\u00e1nu l\u00e9\u010dby, kter\u00fd v\u00e1m l\u00e9ka\u0159 p\u0159edepisuje. a Keytruda l\u00e9\u010d\u00ed ur\u010dit\u00e9 typy rakoviny. Pat\u0159\u00ed tak\u00e9 do stejn\u00e9 t\u0159\u00eddy l\u00e9k\u016f. Z tohoto d\u016fvodu mohou tyto l\u00e9ky zp\u016fsobit n\u011bkter\u00e9 stejn\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky, stejn\u011b jako n\u011bkter\u00e9 r\u016fzn\u00e9. N\u011bkter\u00e9 z t\u011bchto vedlej\u0161\u00edch \u00fa\u010dink\u016f jsou uvedeny n\u00ed\u017ee. V\u00edce informac\u00ed o vedlej\u0161\u00edch \u00fa\u010dinc\u00edch t\u011bchto dvou l\u00e9k\u016f naleznete v p\u0159\u00edru\u010dce pro l\u00e9ky Opdivo a p\u0159\u00edru\u010dku pro l\u00e9ky Keytrudy. Ofdivo a Keytruda, stejn\u011b jako n\u011bkter\u00e9, kter\u00e9 ob\u011b drogy sd\u00edlej\u00ed. K keytruda se m\u016f\u017ee vyskytnout b\u011b\u017en\u00e1 nachlazen\u00ed <\/p>\n<li> :\n<ul> <\/ul>\n<\/li>\n<li> Bolest b\u0159icha <\/li>\n<ul>\n<li> Bole, kloubov\u00e9 nebo svalov\u00e9 bolesti <\/li>\n<\/ul>\n<ul>\n<li> Sn\u00ed\u017een\u00e1 chu\u0165 k j\u00eddlu <\/li>\n<\/ul>\n<ul>\n<li> Nevolnost a pr\u016fjem <\/li>\n<\/ul>\n<ul>\n<li> \u00danava (nedostatek energie) <\/li>\n<\/ul>\n<ul>\n<li> Du\u0161nost dechu <\/li>\n<\/ul>\n<p> V\u011bt\u0161ina z t\u011bchto vedlej\u0161\u00edch \u00fa\u010dink\u016f m\u016f\u017ee zmizet b\u011bhem n\u011bkolika dn\u016f nebo t\u00fddn\u016f po ka\u017ed\u00e9 d\u00e1vce. Ale pokud jsou z\u00e1va\u017en\u011bj\u0161\u00ed nebo neodch\u00e1zej\u00ed, promluvte si se sv\u00fdm l\u00e9ka\u0159em. <\/p>\n<ul>\n<li> Kolitida (z\u00e1n\u011bt v tlust\u00e9m st\u0159ev\u011b) <\/li>\n<li> Po\u0161kozen\u00ed jater nebo hepatitida (z\u00e1n\u011bt v j\u00e1trech) <\/li>\n<li><\/li>\n<li> Hormon\u00e1ln\u00ed poruchy, jako je hypotyre\u00f3za nebo hypertyre\u00f3za <\/li>\n<li> Z\u00e1n\u011bt, kter\u00fd m\u016f\u017ee ovlivnit jak\u00fdkoli org\u00e1n nebo tk\u00e1\u0148, jako je srdce, o\u010di nebo mozek <\/li>\n<li> Infuzn\u00ed reakce (reakce imunitn\u00edho syst\u00e9mu, ke kter\u00e9 doch\u00e1z\u00ed b\u011bhem nebo kr\u00e1tce po obdr\u017een\u00ed infuze l\u00e9\u010diva) <\/li>\n<li> Probl\u00e9my s ledvinami, v\u010detn\u011b nefritidy (z\u00e1n\u011bt v ledvin\u00e1ch) <\/li>\n<li> pneumonitida (z\u00e1n\u011bt v plic\u00edch) <\/li>\n<li> t\u011b\u017ek\u00e1 alergick\u00e1 reakce <\/li>\n<li> Siln\u00e9 vyr\u00e1\u017eky <\/li>\n<\/ul>\n<p> Pokud m\u00e1te p\u0159i pou\u017e\u00edv\u00e1n\u00ed Opdivo nebo Keytruda v\u00e1\u017en\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky, okam\u017eit\u011b zavolejte sv\u00e9ho l\u00e9ka\u0159e. Pokud se vedlej\u0161\u00ed \u00fa\u010dinky c\u00edt\u00ed ohro\u017euj\u00edc\u00ed \u017eivot nebo v\u011b\u0159\u00edte, \u017ee m\u00e1te l\u00e9ka\u0159skou pohotovost, volejte 911 nebo m\u00edstn\u00ed nouzov\u00e9 \u010d\u00edslo hned. <\/p>\n<p> Pozn\u00e1mka: Dal\u0161\u00ed informace o m\u00edrn\u00fdch a z\u00e1va\u017en\u00fdch vedlej\u0161\u00edch \u00fa\u010dinc\u00edch viz strana \u00da\u010dinky v na\u0161ich \u010dl\u00e1nc\u00edch Opdivo a Keytruda. <\/p>\n<ul>\n<li> Rakovina mo\u010dov\u00e9ho m\u011bch\u00fd\u0159e <\/li>\n<li> Klasick\u00fd Hodgkin\u016fv lymfom <\/li>\n<li> Kolorekt\u00e1ln\u00ed rakovina <\/li>\n<li> rakovina j\u00edcnu <\/li>\n<li> Rakovina ledvin <\/li>\n<li> Rakovina jater <\/li>\n<li> Rakovina k\u016f\u017ee melanomu <\/li>\n<li> Rakovina plic s mal\u00fdmi bu\u0148kami <\/li>\n<li> Rakovina plic s mal\u00fdmi bu\u0148kami <\/li>\n<li> Slo\u017ekov\u00e1 hlava a krk bun\u011b\u010dn\u00e9 hlavy a krk Rakovina <\/li>\n<\/ul>\n<p> Ob\u011b l\u00e9ky jsou doporu\u010dov\u00e1ny v ur\u010dit\u00fdch pokynech z N\u00e1rodn\u00ed komplexn\u00ed s\u00edt\u011b pro rakovinu (NCCN) a National Cancer Institute (NCI) k l\u00e9\u010db\u011b ur\u010dit\u00fdch typ\u016f rakovin. <\/p>\n<p> N\u00e1sleduj\u00edc\u00ed graf uv\u00e1d\u00ed rakoviny, pokyny a zda Opdivo, KE Doporu\u010duje se Ytruda, nebo ob\u011b l\u00e9ky. Rakovina <\/p>\n<td> x <\/td>\n<td> x <\/td>\n<tr>\n<td> Klasick\u00fd Hodgkin\u016fv lymfom <\/td>\n<td> x <\/td>\n<td> x <\/td>\n<\/tr>\n<tr>\n<td> kolorekt\u00e1ln\u00ed rakovina <\/td>\n<td> x <\/td>\n<td> x <\/td>\n<td> rakovina j\u00edcnu <\/td>\n<td>*<\/td>\n<td> x <\/td>\n<\/tr>\n<tr>\n<td> rakovina ledvin <\/td>\n<td> nci <\/td>\n<td> x <\/td>\n<td> x <\/td>\n<td> rakovina jater <\/td>\n<td> nci <\/td>\n<td> x <\/td>\n<td> \u2020 <\/td>\n<\/tr>\n<td> Melanomov\u00e1 rakovina k\u016f\u017ee <\/td>\n<td> x <\/td>\n<td> x <\/td>\n<tr>\n<td> Nesmalan\u00fd rakovina plic <\/td>\n<td> nci <\/td>\n<td> x <\/td>\n<td> x <\/td>\n<\/tr>\n<tr>\n<td> rakovina plic s mal\u00fdmi bu\u0148kami <\/td>\n<td> nci <\/td>\n<td>X<\/td>\n<td>X<\/td>\n<\/tr>\n<tr>\n<td>Squamous cell head and neck cancer<\/td>\n<td>X<\/td>\n<td>X<\/td>\n<\/tr>\n<p> Informace o tom, jak tyto l\u00e9ky prov\u00e1d\u011bly v klinick\u00fdch studi\u00edch, naleznete v p\u0159edepisov\u00e1n\u00ed informac\u00ed o Opdivo a Keytru. <\/p>\n<p>* Opdivo byl schv\u00e1len l\u00e9\u010dit rakovinu j\u00edcnu v roce 2020. Pokyny jsou od roku 2019 a nebyly Aktualizov\u00e1no tak, aby bylo mo\u017en\u00e9 doporu\u010dit Opdivo. \u2020 Pro rakovinu jater je Keytruda uvedena jako \u201evy\u0161et\u0159ovan\u00e1\u201c, co\u017e znamen\u00e1, \u017ee je zapot\u0159eb\u00ed v\u00edce studi\u00ed. Pl\u00e1n l\u00e9\u010dby v\u00e1\u0161 l\u00e9ka\u0159 p\u0159edepisuje, v\u00e1\u0161 pojistn\u00fd pl\u00e1n a l\u00e9k\u00e1rnu. Bude tak\u00e9 z\u00e1le\u017eet na n\u00e1klad\u016f na n\u00e1v\u0161t\u011bvu va\u0161eho poskytovatele zdravotn\u00ed p\u00e9\u010de p\u0159i dost\u00e1v\u00e1n\u00ed d\u00e1vek obou l\u00e9k\u016f. Odhady cen pro Opdivo a Keytruda najdete na goodrx.com. Neexistuj\u00ed biosimilar verze obou l\u00e9k\u016f. L\u00e9ky zna\u010dky jsou \u010dasto dra\u017e\u0161\u00ed ne\u017e biosimilars. tv\u00e9 zdrav\u00ed. Zde jsou ozna\u010dov\u00e1ny jako varov\u00e1n\u00ed. Ob\u011b drogy sd\u00edlej\u00ed n\u011bkter\u00e1 stejn\u00e1 varov\u00e1n\u00ed, ale maj\u00ed tak\u00e9 r\u016fzn\u00e1. N\u011bkter\u00e1 z t\u011bchto varov\u00e1n\u00ed jsou uvedena n\u00ed\u017ee. Varov\u00e1n\u00ed pro Opdivo: <\/p>\n<ul>\n<li> \u017d\u00e1dn\u00e1 jedine\u010dn\u00e1 varov\u00e1n\u00ed <\/li>\n<\/ul>\n<li> Varov\u00e1n\u00ed pro Keytruda:\n<ul> <\/ul>\n<\/li>\n<li> Po ur\u010dit\u00e9 l\u00e9\u010db\u011b mnoho\u010detn\u00e9ho myelomu <\/li>\n<li> Varov\u00e1n\u00ed pro Opdivo a Keytruda:\n<ul> <\/ul>\n<\/li>\n<li> Alergick\u00e1 reakce <\/li>\n<ul>\n<li> Probl\u00e9my s imunitn\u00edm syst\u00e9mem, jako je Lupus <\/li>\n<\/ul>\n<ul>\n<li> P\u0159\u00edjemce transplantace org\u00e1n\u016f <\/li>\n<\/ul>\n<ul>\n<li> P\u0159\u00edjemce transplantace alogenn\u00edch hematopoietick\u00fdch kmenov\u00fdch bun\u011bk <\/li>\n<\/ul>\n<ul><\/ul>\n<ul>\n<li> Minul\u00e1 l\u00e9\u010dba radia\u010dn\u00ed terapi\u00ed na hrudi <\/li>\n<\/ul>\n<ul>\n<li> Probl\u00e9my s nervov\u00fdm syst\u00e9mem, jako je syndrom Myasthenia Gravis nebo Guillain-Barre Syndrom <\/li>\n<\/ul>\n<p> Pozn\u00e1mka: Komplexn\u011bj\u0161\u00ed informace o t\u011bchto dvou drog\u00e1ch naleznete na na\u0161ich \u010dl\u00e1nc\u00edch Opdivo a Keytruda. Typy rakoviny, m\u016f\u017eete b\u00fdt schopni p\u0159ej\u00edt z jednoho l\u00e9ku na druh\u00fd. V z\u00e1vislosti na l\u00e9\u010den\u00e9 rakovin\u011b mohou existovat konkr\u00e9tn\u00ed doporu\u010den\u00ed, pro kter\u00e1 je t\u0159eba l\u00e9k pou\u017e\u00edt nejprve nebo jak p\u0159ej\u00edt z jednoho na druhou. V\u00e1\u0161 l\u00e9ka\u0159 bude moci poskytnout podrobn\u00e9 informace o p\u0159echodu mezi Opdivo a Keytruda na z\u00e1klad\u011b stavu, kter\u00fdm dost\u00e1v\u00e1te l\u00e9\u010dbu. Vy. Kl\u00ed\u010dov\u00e9 body, kter\u00e9 si pamatujete p\u0159i porovn\u00e1v\u00e1n\u00ed t\u011bchto l\u00e9k\u016f, pat\u0159\u00ed: <\/p>\n<ul>\n<li> Opdivo a Keytruda jsou biologick\u00e9 l\u00e9ky. Neexistuj\u00ed biosimilar verze obou l\u00e9k\u016f. L\u00e9ky zna\u010dky jsou \u010dasto dra\u017e\u0161\u00ed ne\u017e biosimilars. <\/li>\n<li> Ob\u011b l\u00e9ky mohou zp\u016fsobit mnoho stejn\u00fdch z\u00e1va\u017en\u00fdch vedlej\u0161\u00edch \u00fa\u010dink\u016f. Podrobnosti viz \u010d\u00e1st \u201eVedlej\u0161\u00ed \u00fa\u010dinky Opdivo vs. Keytruda\u201c v\u00fd\u0161e. <\/li>\n<li> Infuze Opdivo jsou pod\u00e1v\u00e1ny ka\u017ed\u00e9 2, 3, 4 nebo 6 t\u00fddn\u016f. Infuze Keytruda se pod\u00e1vaj\u00ed ka\u017ed\u00e9 3 nebo 6 t\u00fddn\u016f. V\u00e1\u0161 rozvrh infuze bude z\u00e1viset na stavu, kter\u00fd pou\u017e\u00edv\u00e1te l\u00e9k k l\u00e9\u010db\u011b, a na konkr\u00e9tn\u00edm pl\u00e1nu l\u00e9\u010dby, kter\u00fd v\u00e1m l\u00e9ka\u0159 p\u0159edepisuje. <\/li>\n<\/ul>\n<p> Pokud byste se cht\u011bli dozv\u011bd\u011bt v\u00edce o Opdivo nebo Keytrud\u011b , promluvte si se sv\u00fdm l\u00e9ka\u0159em nebo l\u00e9k\u00e1rn\u00edkem. Mohou pomoci odpov\u011bd\u011bt na jak\u00e9koli dotazy t\u00fdkaj\u00edc\u00ed se podobnost\u00ed a rozd\u00edl\u016f mezi drogami. Dnes vynalo\u017eila ve\u0161ker\u00e9 \u00fasil\u00ed, aby se ujistilo, \u017ee v\u0161echny informace <a href=\"https:\/\/recenzeproduktu.top\/keraderm\/\">keraderm opravdu funguje<\/a> jsou fakticky korektn\u00ed, komplexn\u00ed a aktu\u00e1ln\u00ed. Tento \u010dl\u00e1nek by v\u0161ak nem\u011bl b\u00fdt pou\u017e\u00edv\u00e1n jako n\u00e1hrada za znalosti a odborn\u00e9 znalosti licencovan\u00e9ho zdravotnick\u00e9ho pracovn\u00edka. P\u0159ed u\u017e\u00edv\u00e1n\u00edm l\u00e9k\u016f byste se m\u011bli v\u017edy poradit se sv\u00fdm l\u00e9ka\u0159em nebo jin\u00fdm zdravotnick\u00fdm odborn\u00edkem. Informace o l\u00e9\u010divech obsa\u017een\u00fdch v tomto dokumentu se vztahuj\u00ed na zm\u011bnu a nen\u00ed ur\u010dena k pokryt\u00ed v\u0161ech mo\u017en\u00fdch pou\u017eit\u00ed, pokyn\u016f, preventivn\u00edch opat\u0159en\u00ed, varov\u00e1n\u00ed, interakc\u00ed s drogami, alergick\u00e9 reakce nebo nep\u0159\u00edzniv\u00e9 \u00fa\u010dinky. Absence varov\u00e1n\u00ed nebo jin\u00fdch informac\u00ed pro dan\u00fd l\u00e9k neznamen\u00e1, \u017ee kombinace l\u00e9\u010diva nebo l\u00e9\u010diva je bezpe\u010dn\u00e1, \u00fa\u010dinn\u00e1 nebo vhodn\u00e1 pro v\u0161echny pacienty nebo v\u0161echny specifick\u00e9 pou\u017eit\u00ed. <\/p>\n<ul>\n<li> Kolorekt\u00e1ln\u00ed rakovina <\/li>\n<li> Rakovina plic <\/li>\n<li> Rakovina\/onkologie <\/li>\n<li> Ucho, nos a krk <\/li>\n<li> Gastrointestinal\/Gastroenterology <\/li>\n<li> Rakovina hlavy a krku <\/li>\n<li> Onemocn\u011bn\u00ed jater\/hepatitida <\/li>\n<li> Melanom\/rakovina k\u016f\u017ee <\/li>\n<li> Pharmacy\/l\u00e9k\u00e1rn\u00edk <\/li>\n<li> Urologie\/nefrologie <\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Opdivo vs. Keytruda \u00davod Opdivo (nivolumab) a Keytruda (Pembrolizumab) jsou l\u00e9ky na p\u0159edpis zna\u010dky. Jsou schv\u00e1leny spr\u00e1vou potravin a l\u00e9\u010div (FDA) k l\u00e9\u010db\u011b ur\u010dit\u00fdch typ\u016f n\u00e1sleduj\u00edc\u00edch rakovin: Rakovina mo\u010dov\u00e9ho m\u011bch\u00fd\u0159e Klasick\u00fd Hodgkin\u016fv lymfom Rakovina kolorekt\u00e1lu Rakovina j\u00edcnu Rakovina ledvin Rakovina jater Rakovina k\u016f\u017ee melanomu Ne-mal\u00fd Rakovina plic bun\u011b\u010dn\u00fdch plic Rakovina plic s mal\u00fdmi bu\u0148kami Slo\u017ekov\u00e1 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.pcube.tech\/blog\/wp-json\/wp\/v2\/posts\/3711"}],"collection":[{"href":"https:\/\/www.pcube.tech\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcube.tech\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcube.tech\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcube.tech\/blog\/wp-json\/wp\/v2\/comments?post=3711"}],"version-history":[{"count":1,"href":"https:\/\/www.pcube.tech\/blog\/wp-json\/wp\/v2\/posts\/3711\/revisions"}],"predecessor-version":[{"id":3712,"href":"https:\/\/www.pcube.tech\/blog\/wp-json\/wp\/v2\/posts\/3711\/revisions\/3712"}],"wp:attachment":[{"href":"https:\/\/www.pcube.tech\/blog\/wp-json\/wp\/v2\/media?parent=3711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcube.tech\/blog\/wp-json\/wp\/v2\/categories?post=3711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcube.tech\/blog\/wp-json\/wp\/v2\/tags?post=3711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}